Skip to main content

Advertisement

SpringerLink
Log in

Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Several classification schemes have been developed for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), with actual debate focusing on their clinical and prognostic performance. Sixty-two patients with renal biopsy-proven AAV from a single center in Mexico City diagnosed between 2004 and 2013 were analyzed and classified under clinical (granulomatosis with polyangiitis [GPA], microscopic polyangiitis [MPA], renal limited vasculitis [RLV]), serological (proteinase 3 anti-neutrophil cytoplasmic antibodies [PR3-ANCA], myeloperoxidase anti-neutrophil cytoplasmic antibodies [MPO-ANCA], ANCA negative), and histopathological (focal, crescenteric, mixed-type, sclerosing) categories. Clinical presentation parameters were compared at baseline between classification groups, and the predictive value of different classification categories for disease and renal remission, relapse, renal, and patient survival was analyzed. Serological classification predicted relapse rate (PR3-ANCA hazard ratio for relapse 2.93, 1.20–7.17, p = 0.019). There were no differences in disease or renal remission, renal, or patient survival between clinical and serological categories. Histopathological classification predicted response to therapy, with a poorer renal remission rate for sclerosing group and those with less than 25 % normal glomeruli; in addition, it adequately delimited 24-month glomerular filtration rate (eGFR) evolution, but it did not predict renal nor patient survival. On multivariate models, renal replacement therapy (RRT) requirement (HR 8.07, CI 1.75–37.4, p = 0.008) and proteinuria (HR 1.49, CI 1.03–2.14, p = 0.034) at presentation predicted renal survival, while age (HR 1.10, CI 1.01–1.21, p = 0.041) and infective events during the induction phase (HR 4.72, 1.01–22.1, p = 0.049) negatively influenced patient survival. At present, ANCA-based serological classification may predict AAV relapses, but neither clinical nor serological categories predict renal or patient survival. Age, renal function and proteinuria at presentation, histopathology, and infectious complications constitute the main outcome predictors and should be considered for individualized management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EK, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11

    Article  CAS  PubMed  Google Scholar 

  2. Schilder AM (2010) Wegener’s granulomatosis vasculitis and granuloma. Autoimmun Rev 9(7):483–7

    Article  CAS  PubMed  Google Scholar 

  3. Villiger PM, Guillevin L (2010) Microscopic polyangiitis: clinical presentation. Autoimmun Rev 9(12):812–9

    Article  PubMed  Google Scholar 

  4. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study Group (EUVAS) (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 67(7):1004–10

    Article  CAS  PubMed  Google Scholar 

  5. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, Höglund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K, European Vasculitis Study Group (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70(3):488–94

    Article  PubMed  Google Scholar 

  6. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenber CG et al (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37:187–92

    Article  CAS  PubMed  Google Scholar 

  7. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen-Tervaert JW, Scott D (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–7

    Article  PubMed  Google Scholar 

  8. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen-Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrusková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesai V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367:214–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Jayne D (2013) L27. Antibodies versus phenotypes: a clinician’s view. Presse Med 42:579–82

    Article  PubMed  Google Scholar 

  10. Hauer HA, Bajema IM, Van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS) (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62:1732–42

    Article  PubMed  Google Scholar 

  11. Hauer HA, Bajema IM, van Houwelingen C, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS) (2002) Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 61:80–9

    Article  PubMed  Google Scholar 

  12. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noël LH, Pusey CD, Waldherr R, Bruijn JA, Bajema IM (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–36

    Article  PubMed  Google Scholar 

  13. Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27(6):2343–9

    Article  PubMed  Google Scholar 

  14. Hilhorst M, Wilde B, van Breda Vriesman P, van Paassen P, Cohen Tervaert JW, Limburg Renal Registry (2013) Estimating renal survival using the ANCA-associated GN classification. J Am Soc Nephrol 24:1371–75

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Muso E, Endo T, Itabashi M, Kakita H, Iwasaki Y, Tateishi Y, Komiya T, Ihara T, Yumura W, Sugiyama T, Joh K, Suzuki K (2013) Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol 17:659–62

    Article  CAS  PubMed  Google Scholar 

  16. Iwakiri T, Fujimoto S, Kitagawa K, Furuichi K, Yamahana J, Matsuura Y, Yamashita A, Uezono S, Shimao Y, Hisanaga S, Tokura T, Wada T, Kitamura K, Asada Y (2013) Validation of a newly proposed histopathological classification in Japanese patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. BMC Nephrol 14:125–33

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ford S, Polkinghome K, Longano A, Dowling J, Dayan S, Kerr PG, Holdsworth SR, Kitching AR, Summers SA (2014) Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis. Am J Kidney Dis 63(2):227–35

    Article  PubMed  Google Scholar 

  18. Ellis CL, Manno RL, Havill JP, Racusen LC, Geetha D (2013) Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome. BMC Nephrol 14:210

    Article  PubMed  PubMed Central  Google Scholar 

  19. Quintana LF, Peréz NS, De Sousa E, Rodas LM, Griffiths MH, Solé M, Jayne D (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29:1764–9

    Article  CAS  PubMed  Google Scholar 

  20. Mukhtyar C, Lee R, Brown D, Carruhters D, Dasgupta B, Dubey P, Muir,, Scott D, Young L, Luqmani RA. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009; 68(12):1827–32.

  21. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monahc PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group (2010) N Engl J Med 363(3):221–32

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. de Joode AAE, Sanders JAF, Stegeman CA (2013) Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol 8:1709–17

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides. Arthritis Rheum 64(10):3452–62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Walsh M, Flossmann O, Berden A, Westman K, Höglund P, Stegeman C, Jayne D; European Vasculitis Study Group. Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheum 2012; 64(2):542–8.

  25. Itabashi M, Takei T, Yabuki Y, Suzuki H, Ado M, Akamatsu M, Yamazaki M, Mitobe M, Watanabe Y, Mochizuki T, Nitta K (2010) Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan. Nephron Clin Pract 115:c21–c27

    Article  CAS  PubMed  Google Scholar 

  26. Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, Nachman PH (2008) Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody–associated small-vessel vasculitis. Arthritis Rheum 58(9):2908–18

    Article  PubMed  PubMed Central  Google Scholar 

  27. de Lind van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM (2006) Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17:2264–74

    Article  Google Scholar 

  28. Pavone L, Grasselli C, Chierici E, Maggiore U, Garini G, Ronda N, Manganelli P, Pesci A, Rioda WT, Tumiati B, Pavesi G, Vaglio A, Buzio C, Secondary and Primar Vasculitides (Se.Pri.Va) Study Group (2006) Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol 33(7):1299–1306

    PubMed  Google Scholar 

  29. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621–31

    Article  PubMed  Google Scholar 

  30. Rihova Z, Jancova E, Merta M, Rysava R, Reiterova J, Zabka J, Tesar V (2005) Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement. Kidney Blood Press Res 28:144–52

    Article  PubMed  Google Scholar 

  31. Neumann I, Kain R, Regele H et al (2005) Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis. Nephrol Dial Transplant 20:96–104

    Article  PubMed  Google Scholar 

  32. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD (2004) ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 19(6):1403–11

    Article  PubMed  Google Scholar 

  33. Booth AD, Almond AK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR, Pan-Thames Renal Research Group (2003) Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41:776–84

    Article  PubMed  Google Scholar 

  34. Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36–44

    Article  CAS  PubMed  Google Scholar 

  35. Hogan SL, Nachman RJ, Wilkman AS, Jennette JC, Falk RJ (1996) Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7(1):23–32

    CAS  PubMed  Google Scholar 

  36. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG (2001) Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 60:170–2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17:611–14

    Article  PubMed  PubMed Central  Google Scholar 

  38. Flores-Suárez LF, Villa AR (2007) Spectrum of Wegener granulomatosis in a Mexican population. Ann N Y Acad Sci 1107:400–9

    Article  PubMed  Google Scholar 

  39. Chen M, Kallenberg CG, Zhao MH (2009) ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol 5(6):313–8

    Article  CAS  PubMed  Google Scholar 

  40. Slot MC, Tervaert JW, Franssen CF, Stegeman CA (2003) Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 63(2):670–77

    Article  PubMed  Google Scholar 

  41. Suppiah R, Flossman O, Mukhtyar C, Alberici F, Baslund B, Brown D, Hasan N, Holle J, Hruskova Z, Jayne D, Judge A, Little MA, Merkel PA, Palmisano A, Seo P, Stegeman C, Tesar V, Vaglio A, Westman K, Luqmani R (2011) Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index. Ann Rheum Dis 70(1):80–5

    Article  PubMed  Google Scholar 

  42. Weiner M, Goh SM, Mohammad AJ et al (2015) Outcome and treatment of elderly patients with ANCA-associated vasculitis. Clin J Am Soc Nephrol 10:1128–35

    Article  PubMed  Google Scholar 

  43. Charlier C, Henegar C, Launay O, Pagnoux C, Berezné A, Bienvenu B, Cohen P, Mouthon L, Guillevin L (2009) Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis 68(5):658–63

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga #15, Sección XVI Belisario Domínguez, Delegación Tlalpan, Mexico City, Mexico

    Bertha M. Córdova-Sánchez, Juan M. Mejía-Vilet, Luis E. Morales-Buenrostro & Ricardo Correa-Rotter

  2. Department of Pathologic Anatomy and Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga #15, Sección XVI Belisario Domínguez, Delegación Tlalpan, Mexico City, Mexico

    Georgina Loyola-Rodríguez & Norma O. Uribe-Uribe

Authors
  1. Bertha M. Córdova-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan M. Mejía-Vilet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis E. Morales-Buenrostro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Georgina Loyola-Rodríguez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Norma O. Uribe-Uribe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ricardo Correa-Rotter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ricardo Correa-Rotter.

Ethics declarations

Disclosures

None.

Funding statement

This work was performed with local resources of the Department of Nephrology and Mineral Metabolism, National Medical Science and Nutrition Institute Salvador Zubiran, Mexico City.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Córdova-Sánchez, B.M., Mejía-Vilet, J.M., Morales-Buenrostro, L.E. et al. Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol 35, 1805–1816 (2016). https://doi.org/10.1007/s10067-016-3195-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3195-z

Keywords

Search

Navigation